6533b851fe1ef96bd12a98b4

RESEARCH PRODUCT

Induction of stress resistance and extension of lifespan in Chaenorhabditis elegans serotonin-receptor knockout strains by withanolide A

Sara AbdelfatahThomas A. EfferthJanine Naß

subject

LongevityPharmaceutical SciencePharmacologyWithaniamedicine.disease_cause03 medical and health sciencesGene Knockout Techniques0302 clinical medicineFluoxetineDrug DiscoverymedicineAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsWithanolidesCaenorhabditis elegansSerotonin transporter5-HT receptor030304 developmental biologyPharmacology0303 health sciencesFluoxetinebiologyPlant ExtractsWild typebiology.organism_classificationMolecular Docking SimulationOxidative StressComplementary and alternative medicine030220 oncology & carcinogenesisReceptors Serotoninbiology.proteinAntidepressantMolecular MedicineSerotoninReactive Oxygen SpeciesOxidative stressmedicine.drug

description

Abstract Introduction Approximately 300 million people worldwide suffer from depression. The COVID-19 crisis may dramatically increase these numbers. Severe side effects and resistance development limit the use of standard antidepressants. The steroidal lactone withanolide A (WA) from Withania somnifera may be a promising alternative. Caenorhabditis elegans was used as model to explore WA's anti-depressive and anti-stress potential. Methods C. elegans wildtype (N2) and deficient strains (AQ866, DA1814, DA2100, DA2109 and MT9772) were used to assess oxidative, osmotic or heat stress as measured by generation of reactive oxygen species (ROS), determination of lifespan, and mRNA expression of serotonin receptor (ser-1, ser-4, ser-7) and serotonin transporter genes (mod-5). The protective effect of WA was compared to fluoxetine as clinically established antidepressant. Additionally, WA's effect on lifespan was determined. Furthermore, the binding affinities and pKi values of WA, fluoxetine and serotonin as natural ligand to Ser-1, Ser-4, Ser-7, Mod-5 and their human orthologues proteins were calculated by molecular docking. Results Baseline oxidative stress was higher in deficient than wildtype worms. WA and fluoxetine reduced ROS levels in all strains except MT9772. WA and fluoxetine prolonged survival times in wildtype and mutants under osmotic stress. WA but not fluoxetine increased lifespan of all heat-stressed C. elegans strains except DA2100. Furthermore, WA but not fluoxetine extended lifespan in all non-stressed C. elegans strains. WA also induced mRNA expression of serotonin receptors and transporters in wildtype and mutants. WA bound with higher affinity and lower pKi values to all C. elegans and human serotonin receptors and transporters than serotonin, indicating that WA may competitively displaced serotonin from the binding pockets of these proteins. Conclusion WA reduced stress and increased lifespan by ROS scavenging and interference with the serotonin system. Hence, WA may serve as promising candidate to treat depression.

10.1016/j.phymed.2021.153482http://dx.doi.org/10.1016/j.phymed.2021.153482